Other
Depreciation
West Pharmaceutical Services Depreciation decreased by 3.9% to $44.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.1%, from $39.10M to $44.60M. Over 4 years (FY 2021 to FY 2025), Depreciation shows an upward trend with a 9.6% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026Apr 23, 2026
How to read this metric
High depreciation relative to revenue may indicate a capital-intensive business model or significant recent investment in infrastructure.
Detailed definition
The systematic allocation of the cost of tangible assets over their useful lives. This non-cash expense reflects the wea...
Peer comparison
Standard accounting metric across all capital-intensive industries.
Metric ID:
other_depreciationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.70M | $28.90M | $32.30M | $28.70M | $29.20M | $28.90M | $30.10M | $30.70M | $33.60M | $34.80M | $34.60M | $34.70M | $38.00M | $39.30M | $39.80M | $39.10M | $40.80M | $42.30M | $46.40M | $44.60M |
| QoQ Change | — | +4.3% | +11.8% | -11.1% | +1.7% | -1.0% | +4.2% | +2.0% | +9.4% | +3.6% | -0.6% | +0.3% | +9.5% | +3.4% | +1.3% | -1.8% | +4.3% | +3.7% | +9.7% | -3.9% |
| YoY Change | — | — | — | — | +5.4% | +0.0% | -6.8% | +7.0% | +15.1% | +20.4% | +15.0% | +13.0% | +13.1% | +12.9% | +15.0% | +12.7% | +7.4% | +7.6% | +16.6% | +14.1% |
Range$27.70M – $46.40M
CAGR+10.5%
Avg YoY Growth+10.5%
Median YoY Growth+13.0%
Depreciation at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's depreciation?
- West Pharmaceutical Services (WST) reported depreciation of $44.60M in Q1 2026.
- How has West Pharmaceutical Services's depreciation changed year-over-year?
- West Pharmaceutical Services's depreciation increased by 14.1% year-over-year, from $39.10M to $44.60M.
- What is the long-term trend for West Pharmaceutical Services's depreciation?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's depreciation has grown at a 9.6% compound annual growth rate (CAGR), from $116.90M to $168.60M.
- What does depreciation mean?
- The annual expense representing the aging and usage of physical assets.